Technology | Cardiovascular Ultrasound | August 22, 2018

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

Epiq CVx line offers cardiologists tailored applications for diagnostic, pediatric and interventional echocardiography with faster data processing, sharper imaging, robust automated quantification and customizable exam tools

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

August 22, 2018 — Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“The EPIQ CVx brings together advanced image quality, quantification and intelligence specifically for the cardiologist,” said Roberto Lang, M.D., professor of medicine, director, Noninvasive Cardiac Imaging Laboratory at the University of Chicago Medicine. “I was impressed with the TrueVue feature, which elevates 3-D ultrasound imaging to a totally new level and could impact diagnostic ability of echocardiography in different clinical scenarios, like better understanding of the anatomy of mitral valves.”

As pressures on healthcare systems around the world continue to increase, cardiologists have more patients to examine in less time, according to Philips. By using advanced 3-D organ modeling, image slicing and proven quantification, the company said its anatomical intelligence is helping make ultrasound exams easier to perform and more reproducible.

Philips described the Epiq CVxi as a third-generation integrated ultrasound-angiography cath lab solution for real-time, workflow-optimized image guidance and advanced quantification for structural heart procedures.

Debuting at the European Society of Cardiology (ESC) 2018 annual meeting, Aug. 25-29 in Munich, Germany, the Epiq CVx includes higher processing power, exceptional image clarity and sharpness, improved exam efficiencies, and more robust and reproducible quantification, enabled by anatomical intelligence. The system includes TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. It provides cardiologists with high image quality through the latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison.

The system offers a variety of new features including Dynamic Heart Model. Building on Philips HeartModelA.I., it uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. Dynamic Heart Model has been shown to reduce the amount of time to generate a 3-D ejection fraction, an important measurement in determining how well the heart is pumping out blood, by 83 percent [2]. It also delivers a high level of robustness and reproducibility, even for patients with an arrhythmia. The systems also includes the new S9-2 PureWave Transducer, which simplifies pediatric cardiac imaging exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances pediatric capability for coronary artery visualization.

The Epiq CVx includes a cardiology-specific user interface that simplifies the exam experience through a user-configurable touch-screen interface, allowing clinicians to personalize their controls and improve workflow for their cardiology exams. The system features strong security capabilities and protocols.

The Epiq CVxi with EchoNavigator, designed specifically for use in the cath lab, is Philips’ third-generation interventional solution to streamline communication between the interventional cardiologist and the echocardiographer during complex interventional exams. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigator helps interventional cardiologists oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3-D during diagnostic or interventional procedures as the clinician can see multiple and flexible views at once.

For more information: www.usa.philips.com/healthcare

 

References

[1] Results obtained during user demonstrations performed in December 2017 with the Epiq CVx and the iE33 systems. The research was designed and supervised by Use-Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. The various types of cardiac customer segments represented were adult diagnostics and interventional, adult diagnostics, and pediatric diagnostics and interventional.

[2] Prado A, Narang A, Volpato V, Kumari N, Prater D, Addetia K, Patel AR, Mor-Avi V, Lang RM: Automated dynamic measurement of left heart chamber volumes for quantification of ejection and filling parameters. JASE 31(6):B111; 2018

 

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick

News | Cardiac Imaging | August 28, 2019
A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs
News | Angiography | August 21, 2019
Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...